Tariq Musa 4

What Happened

• Tariq Musa, a director of Guardant Health, reported derivative activity dated 2026-02-15. The filing shows a conversion/exercise event in which 250 shares were acquired at $0.00 and a simultaneous disposition of 250 shares at $0.00. Both transactions report $0 total value.
• This filing is tied to restricted stock unit (RSU) vesting rather than a cash purchase or open-market sale.

Key Details

• Transaction date: 2026-02-15; Form 4 filed: 2026-02-17 (filed within the typical 2-business-day reporting window).
• Reported transactions: Exercise/conversion of derivative (code M) — 250 shares acquired @ $0.00; 250 shares disposed @ $0.00.
• Reported dollar value: $0 for both acquisition and disposition.
• Shares owned after transaction: Not specified in the provided data.
• Footnotes: F1 notes the RSU award (granted Mar 6, 2023) vests over four years (25% after one year, then monthly over the next three years). F2: Not applicable for RSUs.

Context

• For retail investors: "M" (derivative exercise/conversion) here appears related to vested RSUs being converted into common stock. The simultaneous $0.00 disposition often reflects an administrative action tied to vesting (for example, tax withholding or share settlement mechanics) rather than an open-market sale for cash.
• These items are generally routine administrative events tied to compensation vesting; they do not, by themselves, indicate a buy or sell signal from the insider.